Jin-Feng Xiang

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Wen-Quan Wang · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
2. Jin Xu · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
3. Huaxiang Xu · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
4. Liang Liu · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
5. Jiang Long · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
6. Chuntao Wu · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
7. Xianjun Yu · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
8. Chen Liu · 3 shared papers, 2016–2017 · strength 0.17
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
   • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
9. Zi-Hao Qi · 2 shared papers, 2016–2017 · strength 0.12
   • Paper Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outco… DOI 10.1016/j.surg.2016.08.005↗
   • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
10. Min Li · 2 shared papers, 2016 · strength 0.10
    • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
    • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
11. De-Liang Fu · 1 shared paper, 2016 · strength 0.05
    • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗
12. Jingxuan Yang · 1 shared paper, 2016 · strength 0.05
    • Paper Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients wi… DOI 10.1038/srep19222↗
13. Courtney W. Houchen · 1 shared paper, 2016 · strength 0.05
    • Paper Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated… DOI 10.18632/oncotarget.6819↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.